涉医药行贿,辉瑞愿赔4.3亿元

新浪医药
06 Feb

当地时间1月24日,美国司法部发布声明称,辉瑞代表其全资子公司Biohaven制药控股公司同意支付5974.6277万美元(约合4.34亿元人民币),以解决以下指控:在辉瑞收购该公司之前,Biohaven在知情的情况下,通过向医疗服务提供者支付回扣,诱使其开具Biohaven药品Nurtec ODT的处方,从而导致向医疗 保险 和其它联邦医疗保健计划提交虚假索赔。此前,辉瑞曾被一名前合规经理起诉在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10